RU2369634C2 - Способ культивирования клеток без компонентов животного происхождения - Google Patents

Способ культивирования клеток без компонентов животного происхождения Download PDF

Info

Publication number
RU2369634C2
RU2369634C2 RU2005125606/13A RU2005125606A RU2369634C2 RU 2369634 C2 RU2369634 C2 RU 2369634C2 RU 2005125606/13 A RU2005125606/13 A RU 2005125606/13A RU 2005125606 A RU2005125606 A RU 2005125606A RU 2369634 C2 RU2369634 C2 RU 2369634C2
Authority
RU
Russia
Prior art keywords
cells
medium
cell
animal
virus
Prior art date
Application number
RU2005125606/13A
Other languages
English (en)
Russian (ru)
Other versions
RU2005125606A (ru
Inventor
Бригитт Гислен Луиз АЭРТС (BE)
Бригитт Гислен Луиз АЭРТС
Ив Жюль Морис ГИСЛЭН (BE)
Ив Жюль Морис ГИСЛЭН
Мари-Моник Жан ГОНЗ (BE)
Мари-Моник Жан ГОНЗ
Изабель Соланж Люси НОТТ (BE)
Изабель Соланж Люси НОТТ
Карин МАДЖЕТТО (BE)
Карин МАДЖЕТТО
Original Assignee
ГлаксоСмитКлайн Байолоджикалз с.а.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГлаксоСмитКлайн Байолоджикалз с.а. filed Critical ГлаксоСмитКлайн Байолоджикалз с.а.
Publication of RU2005125606A publication Critical patent/RU2005125606A/ru
Application granted granted Critical
Publication of RU2369634C2 publication Critical patent/RU2369634C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2005125606/13A 2003-03-03 2004-03-01 Способ культивирования клеток без компонентов животного происхождения RU2369634C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304799.0A GB0304799D0 (en) 2003-03-03 2003-03-03 Novel method
GB0304799.0 2003-03-03

Publications (2)

Publication Number Publication Date
RU2005125606A RU2005125606A (ru) 2006-03-10
RU2369634C2 true RU2369634C2 (ru) 2009-10-10

Family

ID=9953995

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005125606/13A RU2369634C2 (ru) 2003-03-03 2004-03-01 Способ культивирования клеток без компонентов животного происхождения

Country Status (17)

Country Link
US (1) US8034617B2 (https=)
EP (3) EP2186885A1 (https=)
JP (2) JP4787739B2 (https=)
KR (1) KR101242090B1 (https=)
CN (2) CN1756837B (https=)
AU (1) AU2004217807B2 (https=)
BR (1) BRPI0407636A (https=)
CA (1) CA2517327A1 (https=)
CO (1) CO5601047A2 (https=)
GB (1) GB0304799D0 (https=)
IS (1) IS7992A (https=)
MA (1) MA27631A1 (https=)
MX (1) MXPA05009096A (https=)
NO (1) NO20054124L (https=)
NZ (1) NZ541908A (https=)
RU (1) RU2369634C2 (https=)
WO (1) WO2004078955A1 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2612915C2 (ru) * 2011-02-28 2017-03-13 Президент Энд Феллоуз Ов Харвард Колледж Система культивирования клеток
US9833482B2 (en) 2011-12-08 2017-12-05 Yeda Research And Development Co. Ltd. Mammalian fetal pulmonary cells and therapeutic use of same
RU2644651C2 (ru) * 2010-04-26 2018-02-13 Новартис Аг Среда для культивирования клеток
US10184106B2 (en) 2012-06-20 2019-01-22 Genentech, Inc. Methods for viral inactivation and other adventitious agents
RU2678142C2 (ru) * 2012-04-24 2019-01-23 Дженентек, Инк. Способ культивирования клеток млекопитающих и получение полипептидов с использованием композиции клеточной культуры
US10668109B2 (en) 2015-06-18 2020-06-02 Yeda Research And Development Co. Ltd. Conditioning protocols and use of same for tissue regeneration

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2396689T3 (es) 2003-12-11 2013-02-25 Isto Technologies Inc. Sistema de cartílago particulado
JP4650798B2 (ja) 2004-04-19 2011-03-16 デンカ生研株式会社 ウイルスの生産方法
AU2005302516A1 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
JP4693839B2 (ja) * 2005-03-10 2011-06-01 共立製薬株式会社 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP2008541746A (ja) * 2005-06-03 2008-11-27 ビオヴィトルム・アクチボラゲット（プブリクト） 新規プロセス
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
KR101594046B1 (ko) 2008-01-09 2016-02-15 첼카 게엠베하 개선된 배양 배지 첨가제 및 이를 이용한 방법
PE20110992A1 (es) 2009-02-17 2012-02-12 Glaxosmithkline Biolog Sa Composicion inmunogenica que comprende un antigeno del virus del dengue
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
JP6041199B2 (ja) * 2012-09-14 2016-12-07 国立大学法人大阪大学 三次元細胞培養体の製造方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US10004795B2 (en) * 2015-09-08 2018-06-26 Fundacao Butantan Process for preparing an attenuated tetravalent dengue vaccine
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
CN105567628B (zh) * 2016-01-30 2019-07-12 令世鑫 一种全悬浮培养mdck细胞的低血清培养基
CN105779376B (zh) * 2016-03-24 2019-08-30 友康恒业生物科技（北京）有限公司 一种流感病毒分离无血清培养基及其用途和制备
CN105695393B (zh) * 2016-03-24 2019-09-10 友康恒业生物科技（北京）有限公司 一种mdck细胞无血清培养基及其用途和制备
KR101925079B1 (ko) * 2017-05-24 2018-12-04 가천대학교 산학협력단 Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법
CN107432931B (zh) * 2017-08-03 2018-04-13 长春祈健生物制品有限公司 一种微载体培养水痘病毒制备疫苗的方法
MX2021006115A (es) 2019-01-17 2021-07-07 Boehringer Ingelheim Animal Health Usa Inc Medio libre de suero para produccion de vacuna aviar y usos del mismo.
KR20220123019A (ko) 2019-12-31 2022-09-05 에어 프로틴 인코포레이티드 고단백질 식품 조성물
EP4093848A4 (en) * 2020-01-24 2024-08-07 Air Protein, Inc. Microorganism-derived protein hydrolysates, and methods of preparation and use thereof
CN113373107B (zh) * 2021-01-29 2022-12-30 上海生物制品研究所有限责任公司 一种大规模制备传代鸡胚细胞生产病毒的方法
WO2024039216A1 (ko) * 2022-08-19 2024-02-22 셀미트주식회사 동물세포 또는 동물 세포주의 배양방법
CN115627255B (zh) * 2022-12-01 2023-04-07 天信和(苏州)生物科技有限公司 一种采用低血清培养基培养人二倍体细胞的方法
KR102926380B1 (ko) * 2025-02-19 2026-02-12 (주)엑셀세라퓨틱스 줄기세포 유래 엑소좀의 제조방법, 엑소좀 및 이를 포함하는 조성물
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型，及其制备方法和用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2057176C1 (ru) * 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94611A (en) * 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4115722A1 (de) 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
EP0666751B1 (en) 1992-09-18 2001-09-12 SMITHKLINE BEECHAM BIOLOGICALS s.a. Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines
CN1088984A (zh) * 1993-11-11 1994-07-06 江西省医学科学研究所 一种用于造血祖细胞培养的无血清培养基
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
CA2205015C (en) 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
WO1998000521A1 (fr) * 1996-06-28 1998-01-08 The Green Cross Corporation Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
WO1998004680A1 (en) * 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
US6103529A (en) * 1996-10-10 2000-08-15 Life Technologies, Inc. Animal cell culture media comprising peptides derived from rice
WO1998059035A2 (en) * 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2775983B1 (fr) 1998-03-13 2000-11-10 Pasteur Merieux Serums Vacc Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) * 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US6623959B2 (en) * 2001-06-13 2003-09-23 Ethicon, Inc. Devices and methods for cell harvesting

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2057176C1 (ru) * 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCHAEFFER W.I. et al. A system employing a minimal defined medium for the selection of tumorigenic cells. In Vitro Cell Dev Biol. 1990 Jul; 26(7):737-40. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644651C2 (ru) * 2010-04-26 2018-02-13 Новартис Аг Среда для культивирования клеток
RU2612915C2 (ru) * 2011-02-28 2017-03-13 Президент Энд Феллоуз Ов Харвард Колледж Система культивирования клеток
US9833482B2 (en) 2011-12-08 2017-12-05 Yeda Research And Development Co. Ltd. Mammalian fetal pulmonary cells and therapeutic use of same
RU2678142C2 (ru) * 2012-04-24 2019-01-23 Дженентек, Инк. Способ культивирования клеток млекопитающих и получение полипептидов с использованием композиции клеточной культуры
US10184106B2 (en) 2012-06-20 2019-01-22 Genentech, Inc. Methods for viral inactivation and other adventitious agents
RU2685203C2 (ru) * 2012-06-20 2019-04-16 Дженентек, Инк. Способы инактивации вирусов и бактерий в клеточной культуральной среде
US10668109B2 (en) 2015-06-18 2020-06-02 Yeda Research And Development Co. Ltd. Conditioning protocols and use of same for tissue regeneration

Also Published As

Publication number Publication date
CO5601047A2 (es) 2006-01-31
US20060183224A1 (en) 2006-08-17
EP2186885A1 (en) 2010-05-19
NO20054124L (no) 2005-09-27
JP2006519023A (ja) 2006-08-24
NZ541908A (en) 2008-04-30
MA27631A1 (fr) 2005-11-01
CN101200705A (zh) 2008-06-18
RU2005125606A (ru) 2006-03-10
EP1599580A1 (en) 2005-11-30
EP2192175A1 (en) 2010-06-02
BRPI0407636A (pt) 2006-02-21
MXPA05009096A (es) 2005-10-19
CA2517327A1 (en) 2004-09-16
WO2004078955A1 (en) 2004-09-16
AU2004217807B2 (en) 2009-06-25
KR20050105509A (ko) 2005-11-04
JP2010273683A (ja) 2010-12-09
KR101242090B1 (ko) 2013-03-08
US8034617B2 (en) 2011-10-11
NO20054124D0 (no) 2005-09-05
IS7992A (is) 2005-08-18
GB0304799D0 (en) 2003-04-09
JP4787739B2 (ja) 2011-10-05
CN1756837A (zh) 2006-04-05
CN1756837B (zh) 2010-05-26
AU2004217807A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
RU2369634C2 (ru) Способ культивирования клеток без компонентов животного происхождения
EP2218776B1 (en) Animal protein-free media for cultivation of cells
RU2612154C2 (ru) Способ культивирования адгезионных клеток
US20120077268A1 (en) Animal-free cell culture method
HK1144104A (en) Animal-free cell culture method
HK1144103A (en) Animal-free cell culture method
US20030104613A1 (en) Method for producing adherent animal cells
HK1083635A1 (zh) 用於细胞培养的无动物蛋白质培养基
HK1083635B (en) Animal protein free media for cultivation of cells
HK1147284B (en) Animal protein-free media for cultivation of cells
HK1108713B (en) Animal protein free media for cultivation of cells
AU2012238257A1 (en) Animal Protein-Free Media for Cultivation of Cells
HK1147110B (en) Animal protein-free media for cultivation of cells

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140302